Showing results (21-30 of 204) with videos related to
Sort By:
Pageof 21
British Journal of Pharmacology|May 1, 1980
Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in ratsJ M Alexandre, C ChevillardBrain Research|August 8, 1983
Selective increase of angiotensin-converting enzyme activity in discrete extrahypothalamic areas of Brattleboro ratsC Chevillard, J M SaavedraLa Revue De Medecine Interne|December 8, 2009
[Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren's syndrome]F Bernard, A Romano, B GranelBritish Journal of Pharmacology|August 1, 1981
Interactions between hydralazine, propildazine and purines on arterial smooth muscleC Chevillard, B Saiag, M WorcelJournal of Cellular Physiology|June 1, 1995
Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell lineD Vittet, C Duperray, C ChevillardClinical Science (London, England : 1979)|December 1, 1980
Hydralazine: mode of action at the neuroarterial junctionC Chevillard, B Saiag, M WorcelMolecular & General Genetics : MGG|June 1, 1978
Catabolite repression in Escherichia coli mutants lacking cyclic AMPA Dessein, M Schwartz, A UllmannMolecular & General Genetics : MGG|June 1, 1978
Catabolite modulator factor: physiological properties and in vivo effectsA Dessein, F Tillier, A UllmannJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1979
Characterization of the primary IgM response to GAT and GT: conditions required for the detection of IgM antibodiesC Waltenbaugh, A Dessein, B BenacerrafThe Journal of Pharmacy and Pharmacology|March 1, 1975
How does angiotensin II increase cardiac dopamine-beta-hydroxylation?C Chevillard, N Duchene, J M AlexandrePageof 21